Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 12, 2025

Primary Completion Date

October 10, 2025

Study Completion Date

October 10, 2025

Conditions
Eustachian Tube Dysfunction
Interventions
OTHER

Buteyko breathing

twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.

OTHER

usual care

twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.

Trial Locations (1)

11432

RECRUITING

Cairo University, Dokki

All Listed Sponsors
lead

Cairo University

OTHER